UK Joins PrSM Programme and Leads NATO Deep Precision Strike Initiative

Three defence investment announcements published on 7 and 8 July 2026 mark a significant expansion of UK long range strike capability and military medical care. The British Army will acquire the Precision Strike Missile (PrSM), the UK is leading a NATO wide deep precision strike initiative at the Ankara Summit, and £50 million is being directed to frontline battlefield medicine. All three draw from the £298 billion Defence Investment Plan published on 30 June 2026.

The announcements span different parts of the armed forces but share a common thread, improving the UK's ability to strike targets far behind a front line, sustain forces in the field, and contribute to NATO deterrence at a time of heightened threat from Russia.

The British Army is joining the Precision Strike Missile programme, a collaborative effort already running between the United States and Australia under AUKUS Pillar 2. The missile is currently built by Lockheed Martin and is a proven supersonic ballistic weapon capable of reaching targets at up to 500 kilometres.

Its key selling point for the UK is immediate compatibility. PrSM works with the Army's existing upgraded M270A2 Multiple Launch Rocket System launchers, meaning no new vehicles or additional infrastructure modifications are needed.

The government has allocated £190 million from the Defence Investment Plan for the procurement. Subject to agreement with the US and Australia, first deliveries could come as early as 2027. Future development work could extend the missile's range further, according to the Ministry of Defence.

Defence Secretary Dan Jarvis MBE MP said the investment would "give our soldiers the weapons they need as they defend our nation and NATO." PrSM is described as a complement to other long range systems already in development rather than a replacement for longer term collaborative programmes.

At the NATO Summit in Ankara on 8 July, Prime Minister Keir Starmer convened European allies to launch a UK led initiative focused on deep precision strike capability. Around twelve countries are expected to commit a combined $50 billion, approximately £37 billion over the next decade to develop and field long range strike weapons across the alliance.

The initiative targets capability able to strike at a minimum of 300 kilometres, with some systems designed for ranges exceeding 2,000 kilometres. The aim is to give NATO forces the ability to degrade enemy logistics, weapons systems, and supply lines well behind a front line before they can threaten allied territory.

UK programmes already in development

The UK's own long range investment forms the backbone of its £3 billion commitment to this area by 2030:

• Trinity House (UK–Germany): A joint programme to develop stealth and hypersonic weapons with a range exceeding 2,000 kilometres, expected to enter service in the 2030s. The UK is investing £770 million over four years.
• Stratus (UK–France–Italy): A trilateral project developing both stealth and high speed variants of a successor to the Storm Shadow cruise missile. Stratus is designed to engage surface targets, warships, and enemy air defences. The UK is investing £1.4 billion over four years, the project sustains more than 1,300 jobs at MBDA facilities in Stevenage and Bolton.
• PrSM (UK–US–Australia): The Army ballistic missile described above, providing an immediately available capability while the longer range bilateral programmes mature.

The Prime Minister said NATO had scrambled fighter jets to intercept Russian aircraft more than 700 times in the past two years and that Russian military activity around UK waters had surged 30 per cent in the same period.

Separately, on 8 July the government published details of £50 million in Defence Medical investment under the Defence Investment Plan. The funding is spread across four specific areas over the next four years:

Beyond this four year package, the government has stated an intention to invest at least £3 billion between 2030 and 2035 in Defence Medical capabilities and Joint Support Enablement covering combat medicine advances, protection against chemical, biological, radiological and nuclear threats, and the logistics needed to sustain the Integrated Force on future operations.

These announcements build on the Defence Investment Plan published a week earlier, but several key details remain to be confirmed. PrSM deliveries in 2027 are subject to formal agreement with the US and Australia. Trinity House and Stratus are both multi year development programmes not expected to reach full capability until the 2030s. The NATO Deep Precision Strike initiative sets spending targets across nations but is not a binding procurement programme.

The government has not published a single consolidated timetable for when these capabilities will reach operational service. For the battlefield medicine investments, the four year funding window runs to roughly 2030, with further commitments described as an intention rather than a confirmed allocation.